Literature DB >> 8985624

Vasopressin release during orthostatic hypotension after cardiac transplantation.

S W Lord1, S Brady, P H Baylis, J H Dark, R A Kenny, J M McComb.   

Abstract

At the time of cardiac transplantation all nerves from the donor ventricles are cut. These nerves may regrow, but there is no method of measuring any regrowth. Arginine vasopressin (AVP) release was studied during hypotension induced by head-up tilt and lower body negative pressure (LBNP) in transplant recipients and in normal controls. Subjects were tilted to 60 degrees for up to 60 min or until symptomatic. Lower body negative pressure (40 mmHg) was applied for 10 min after 30 min rest. Seven of 17 transplant recipients and 11 of 12 controls became symptomatic during tilt testing, and 9 of 12 controls and 9 of 17 transplant recipients became symptomatic after 10 min of LBNP. Symptoms during tilt did not predict symptoms during LBNP. Resting AVP levels were similar but osmolality was greater in transplant recipients. Resting haematocrit was reduced, and atrial natriuretic peptide increased in transplant recipients, suggesting increased plasma volume. In symptomatic subjects, changes in humoral concentrations were similar when compared between transplant recipients and normals, except that the rise in AVP at the time of symptoms was reduced in transplant recipients, with a comparable drop in blood pressure consistent with persistent cardiac afferent denervation in a subset of transplant recipients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8985624     DOI: 10.1007/bf02556306

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  26 in total

1.  Excessive secretion of vasopressin during vasovagal reaction.

Authors:  G A Riegger; A Wagner
Journal:  Am Heart J       Date:  1991-02       Impact factor: 4.749

2.  Renal sympathetic nerve activity and renal responses during head-up tilt in conscious dogs.

Authors:  K Miki; Y Hayashida; F Tajima; J Iwamoto; K Shiraki
Journal:  Am J Physiol       Date:  1989-08

3.  Predicting orthostatic intolerance: physics or physiology?

Authors:  D A Ludwig; V A Convertino
Journal:  Aviat Space Environ Med       Date:  1994-05

4.  Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope.

Authors:  H El-Sayed; R Hainsworth
Journal:  Heart       Date:  1996-02       Impact factor: 5.994

5.  A new radioimmunoassay for human alpha atrial natriuretic peptide and its physiological validation.

Authors:  L M Burrell; J Palmer; J A Charlton; T Thomas; P H Baylis
Journal:  J Immunoassay       Date:  1990

6.  Normalization of circulating atrial natriuretic peptides in cardiac transplant recipients.

Authors:  M W Weston; G B Cintron; A T Giordano; D L Vesely
Journal:  Am Heart J       Date:  1994-01       Impact factor: 4.749

7.  Breakdown of blood pressure and body fluid homeostasis in heart transplant recipients.

Authors:  R W Braith; R M Mills; C S Wilcox; G L Davis; C E Wood
Journal:  J Am Coll Cardiol       Date:  1996-02       Impact factor: 24.094

8.  Preserved atrial natriuretic peptide secretory function after cardiac transplantation.

Authors:  R C Starling; T M O'Dorisio; W B Malarkey; K D Murray; P D Myerowitz; R J Cody
Journal:  Am J Cardiol       Date:  1991-07-15       Impact factor: 2.778

9.  Evidence against reinnervation of cardiac vagal afferents after human orthotopic cardiac transplantation.

Authors:  J A Arrowood; E Goudreau; A J Minisi; A B Davis; P K Mohanty
Journal:  Circulation       Date:  1995-08-01       Impact factor: 29.690

10.  Failure of atrial natriuretic factor to increase with saline load in patients with dilated cardiomyopathy and mild heart failure.

Authors:  M Volpe; C Tritto; N De Luca; A F Mele; G Lembo; S Rubattu; M Romano; P De Campora; I Enea; B Ricciardelli
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.